This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Receptor
From Proteopedia
(Difference between revisions)
| Line 11: | Line 11: | ||
*[[G protein-coupled receptor|G protein-coupled receptors]] | *[[G protein-coupled receptor|G protein-coupled receptors]] | ||
==Kinase-linked, enzyme-linked and related receptors== | ==Kinase-linked, enzyme-linked and related receptors== | ||
| - | === | + | ===Receptor tyrosine kinases=== |
| + | Receptor tyrosine kinases (RTKs) are part of the larger family of protein [[Tyrosine kinase|tyrosine kinases]]. They are the high-affinity cell surface receptors for many polypeptide [[Growth factors|growth factors]], cytokines, and [[Hormone|hormones]]. Approximately 20 different RTK classes have been identified.<ref>PMID:26579483</ref> | ||
| + | *RTK class I [[Epidermal Growth Factor Receptor]] family | ||
| + | *RTK class II [[Insulin receptor]] family | ||
| + | *RTK class III [[Platelet-derived growth factors and receptors|Platelet-derived growth factor receptor]] family | ||
| + | *RTK class IV [[Vascular Endothelial Growth Factor Receptor]] family | ||
| + | *RTK class V [[Fibroblast growth factor receptor]] family | ||
| + | *RTK class VIII [[Hepatocyte growth factor receptor]] family | ||
| + | *RTK class IX [[Ephrin receptor]] family | ||
| + | *RTK class XIII [[Epithelial discoidin domain-containing receptor]] (DDR receptor) family | ||
| + | *Neurotrophin: [[High affinity nerve growth factor receptor]] (or [[Tyrosine kinase receptor]]) and [[TrkB tyrosine kinase receptor]] | ||
| + | *[[Insulin-like growth factor receptor]] | ||
| + | |||
===[[Enzyme-linked receptor]]=== | ===[[Enzyme-linked receptor]]=== | ||
Revision as of 10:19, 7 April 2021
| |||||||||||
References
- ↑ Segaliny AI, Tellez-Gabriel M, Heymann MF, Heymann D. Receptor tyrosine kinases: Characterisation, mechanism of action and therapeutic interests for bone cancers. J Bone Oncol. 2015 Jan 23;4(1):1-12. doi: 10.1016/j.jbo.2015.01.001. eCollection , 2015 Mar. PMID:26579483 doi:http://dx.doi.org/10.1016/j.jbo.2015.01.001
